Gray William K, Navaratnam Annakan V, Day Jamie, Babu Pratusha, Mackinnon Shona, Adelaja Ini, Bartlett-Pestell Sam, Moulton Chris, Mann Cliff, Batchelor Anna, Swart Michael, Snowden Chris, Dyer Philip, Jones Michael, Allen Martin, Hopper Adrian, Rayman Gerry, Kar Partha, Wheeler Andrew, Eve-Jones Sue, Fong Kevin J, Machin John T, Wendon Julia, Briggs Tim W R
Getting It Right First Time programme, NHS England and NHS Improvement, London, UK.
University College Hospital, London, UK.
EClinicalMedicine. 2021 May;35:100859. doi: 10.1016/j.eclinm.2021.100859. Epub 2021 Apr 26.
A key first step in optimising COVID-19 patient outcomes during future case-surges is to learn from the experience within individual hospitals during the early stages of the pandemic. The aim of this study was to investigate the extent of variation in COVID-19 outcomes between National Health Service (NHS) hospital trusts and regions in England using data from March-July 2020.
This was a retrospective observational study using the Hospital Episode Statistics administrative dataset. Patients aged ≥ 18 years who had a diagnosis of COVID-19 during a hospital stay in England that was completed between March 1st and July 31st, 2020 were included. In-hospital mortality was the primary outcome of interest. In secondary analysis, critical care admission, length of stay and mortality within 30 days of discharge were also investigated. Multilevel logistic regression was used to adjust for covariates.
There were 86,356 patients with a confirmed diagnosis of COVID-19 included in the study, of whom 22,944 (26.6%) died in hospital with COVID-19 as the primary cause of death. After adjusting for covariates, the extent of the variation in-hospital mortality rates between hospital trusts and regions was relatively modest. Trusts with the largest baseline number of beds and a greater proportion of patients admitted to critical care had the lowest in-hospital mortality rates.
There is little evidence of clustering of deaths within hospital trusts. There may be opportunities to learn from the experience of individual trusts to help prepare hospitals for future case-surges.
在未来病例激增期间优化新冠肺炎患者治疗效果的关键第一步是借鉴疫情早期各医院的经验。本研究旨在利用2020年3月至7月的数据,调查英国国民医疗服务体系(NHS)医院信托机构和地区之间新冠肺炎治疗效果的差异程度。
这是一项使用医院事件统计行政数据集的回顾性观察研究。纳入了2020年3月1日至7月31日期间在英格兰住院期间被诊断为新冠肺炎的18岁及以上患者。院内死亡率是主要关注的结果。在二次分析中,还调查了重症监护病房收治情况、住院时间和出院后30天内的死亡率。采用多水平逻辑回归对协变量进行调整。
该研究纳入了86356例确诊新冠肺炎患者,其中22944例(26.6%)在医院死亡,新冠肺炎为主要死因。在对协变量进行调整后,医院信托机构和地区之间院内死亡率的差异程度相对较小。床位基线数量最多且入住重症监护病房的患者比例更高的信托机构院内死亡率最低。
几乎没有证据表明医院信托机构内存在死亡聚集现象。或许有机会借鉴个别信托机构的经验,帮助医院为未来的病例激增做好准备。